Jump to content

Template:Medications and dosages used in hormone therapy for transgender women

From Wikipedia, the free encyclopedia

Medications and dosages used in transgender women[1][2][3][4][5][a]
Medication Brand name Type Route Dosage[b]
Estradiol Various Estrogen Oral 2–10 mg/day
Various Estrogen Sublingual 1–8 mg/day
Climara[c] Estrogen TD patch 25–400 μg/day
Divigel[c] Estrogen TD gel 0.5–5 mg/day
Various Estrogen SC implant 50–200 mg every 6–24 mos
Estradiol valerate Progynova Estrogen Oral 2–10 mg/day
Progynova Estrogen Sublingual 1–8 mg/day
Delestrogen[c] Estrogen IM, SC 2–10 mg/wk or
5–20 mg every 2 wks
Estradiol cypionate Depo-Estradiol Estrogen IM, SC 2–10 mg/wk or
5–20 mg every 2 wks
Estradiol dipropionate Agofollin Estrogen IM, SC 2–10 mg/wk or
5–20 mg every 2 wks
Estradiol benzoate Progynon-B Estrogen IM, SC 0.5–1.5 mg every 2–3 days
Estriol Ovestin[c] Estrogen Oral 4–6 mg/day
Spironolactone Aldactone Antiandrogen Oral 100–400 mg/day
Cyproterone acetate Androcur Antiandrogen;
Progestogen
Oral 5–100 mg/day
Androcur Depot IM 300 mg/month
Bicalutamide Casodex Antiandrogen Oral 25–50 mg/day
Enzalutamide Xtandi Antiandrogen Oral 160 mg/day
GnRH analogue Various GnRH modulator Various Variable
Elagolix Orilissa GnRH antagonist Oral 150 mg/day or
200 mg twice daily
Finasteride Propecia 5αR inhibitor Oral 1–5 mg/day
Dutasteride Avodart 5αR inhibitor Oral 0.25–0.5 mg/day
Progesterone Prometrium[c] Progestogen Oral 100–400 mg/day
Medroxyprogesterone acetate Provera Progestogen Oral 2.5–40 mg/day
Depo-Provera Progestogen IM 150 mg every 3 mos
Depo-SubQ Provera 104 Progestogen SC 104 mg every 3 mos
Hydroxyprogesterone caproate Proluton Progestogen IM 250 mg/wk
Dydrogesterone Duphaston Progestogen Oral 20 mg/day
Drospirenone Slynd Progestogen Oral 3 mg/day
Domperidone[d] Motilium Prolactin releaser Oral 30–80 mg/day[e]
  1. ^ Additional sources:[6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36]
  2. ^ Lower starting doses may be used in adolescents if being used in combination with a GnRH agonist or antagonist.
  3. ^ a b c d e Also available under other brand names.
  4. ^ For induction of lactation to allow for breastfeeding specifically.
  5. ^ Administered in divided doses.